ASSOCIATIONS BETWEEN CIRCULATING LEVELS OF PLASMA OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 AND VASCULAR OUTCOMES IN AFRICAN AMERICAN DIABETIC PATIENTS

Ayobami Eluwole,Ajibola M. Adedayo,Fasika Tedla,Arye Kremer,Nicole Mastrogiovanni,Mohammed Afzal,Carl Rosenberg,Paul Dreizen,John La Rosa,Mohamed Boutjdir,Mary Ann Banerji,Clinton D. Brown,Moro O. Salifu,Jason Lazar,Ahmed Bakillah

ASSOCIATIONS BETWEEN CIRCULATING LEVELS OF PLASMA OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 AND VASCULAR OUTCOMES IN AFRICAN AMERICAN DIABETIC PATIENTS

2018

Ayobami Eluwole
Ajibola M. Adedayo
Fasika Tedla
Arye Kremer
Nicole Mastrogiovanni
Mohammed Afzal
Carl Rosenberg
Paul Dreizen
John La Rosa
Mohamed Boutjdir
Mary Ann Banerji
Clinton D. Brown
Moro O. Salifu
Jason Lazar
Ahmed Bakillah

Studies showed conflicting results for the association of circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) with glycemic parameters and risk of type 2 diabetes. Whether plasma levels of PCSK9 could directly influence vascular function is still unclear. The present study aims to

Keywords:

Subtilisin
Kexin
Glycemic
Diabetes mellitus
Type 2 diabetes
Proprotein convertase
PCSK9
Internal medicine
Cardiology
Medicine
Endocrinology
african american

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations